EverydayHealth

In February 2017, Mayo Medical Laboratories announced nine brand new tests along with numerous reference-value changes, obsolete tests, and algorithm changes.

Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.

We have all been in the position of starting something new: a new class, new hobby, or a new job. Imagine yourself arriving for a new endeavor, entering a vacant room with a set of instructions on the chalkboard to complete some paperwork, signing some forms, and then leaving them in a bin when finished with no additional direction on where to go or what to do next . . . . How would that make you feel? Jeffry Harden, Program Manager in Mayo's Staff Development for Laboratory Medicine and Pathology, discusses best practices for orientation and onboarding.

Linnea Baudhuin, Ph.D., Associate Professor of Laboratory Medicine and Pathology and Co-Director of the Personalized Genomics Laboratory, the Clinical Genomics Sequencing Laboratory, and the Cardiovascular Laboratory at Mayo Clinic in Rochester, Minnesota, recently authored an article in "The Pathologist" on the cost of next-generation sequencing.

Mayo Clinic has completed validation of its existing Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum test for the new biosimilar drug Inflectra. Clients[...]

This week’s Research Roundup highlights outcomes of warfarin therapy for bioprosthetic valve thrombosis of surgically implanted valves.

Mike Baisch, Systems Engineer at Mayo Clinic, discusses the mechanics of performing a staffing-to-workload analysis in the testing laboratories. There are three primary areas of focus with staffing needs: direct effort, indirect effort, and operational needs. This post focuses on indirect effort.

Mike Baisch, Systems Engineer at Mayo Clinic, discusses the mechanics of performing a staffing-to-workload analysis in the testing laboratories. There are three primary areas of focus with staffing needs: direct effort, indirect effort, and operational needs. This post focuses on direct effort.

Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that Widseth had antibodies known to target certain brain cells.

In this “Hot Topic,” William Nichols, M.D., presents a case study that demonstrates how pre- and postanalytic variables of the patient and blood samples can have confounding effects on the laboratory evaluation of coagulation disorders.

The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot Topic" to learn about testing for IBD and IBS.

Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated MPGN. In this “Hot Topic,” Senjeev Sethi, M.D., Ph.D., demonstrates the use of the new classification with case studies.

Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated MPGN. In this “Hot Topic,” Senjeev Sethi, M.D., Ph.D., demonstrates the use of the new classification with case studies.